docj
5 minutes ago
In case you found the link didn't work:
Original Article: Clinical Science
Leronlimab Treatment for Multidrug-Resistant HIV-1 (OPTIMIZE): a Randomized, Double-Blind, Placebo-Controlled Trial
Gathe, Joseph C. MDa; Dejesus, Edwin MDb; Ramgopal, Moti N. MDc; Rolle, Charlott
KRISGO
6 minutes ago
Gary, right now, most of us are more focused on getting the approval, especially since it’s been 14 months since the submission, and the stock price is stuck between 25-30 cents with 1.3 billion diluted shares. At this point, any comment on the approval gives us more confidence than anything else. I
ddls
7 minutes ago
2/20/25, Buy: 283,000, Neutral: 30,000, Sell: 2,390,473..😎
Doesn't look like accumulation to me, more like liquidation.